1. Home
  2. AREC vs RLMD Comparison

AREC vs RLMD Comparison

Compare AREC & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREC
  • RLMD
  • Stock Information
  • Founded
  • AREC 2013
  • RLMD 2004
  • Country
  • AREC United States
  • RLMD United States
  • Employees
  • AREC N/A
  • RLMD N/A
  • Industry
  • AREC Coal Mining
  • RLMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • AREC Energy
  • RLMD Health Care
  • Exchange
  • AREC Nasdaq
  • RLMD Nasdaq
  • Market Cap
  • AREC 96.8M
  • RLMD 110.6M
  • IPO Year
  • AREC 2019
  • RLMD N/A
  • Fundamental
  • Price
  • AREC $1.07
  • RLMD $0.36
  • Analyst Decision
  • AREC Strong Buy
  • RLMD Hold
  • Analyst Count
  • AREC 3
  • RLMD 4
  • Target Price
  • AREC $4.33
  • RLMD $4.25
  • AVG Volume (30 Days)
  • AREC 319.2K
  • RLMD 2.1M
  • Earning Date
  • AREC 11-14-2024
  • RLMD 11-07-2024
  • Dividend Yield
  • AREC N/A
  • RLMD N/A
  • EPS Growth
  • AREC N/A
  • RLMD N/A
  • EPS
  • AREC N/A
  • RLMD N/A
  • Revenue
  • AREC $399,962.00
  • RLMD N/A
  • Revenue This Year
  • AREC N/A
  • RLMD N/A
  • Revenue Next Year
  • AREC $3,208.62
  • RLMD N/A
  • P/E Ratio
  • AREC N/A
  • RLMD N/A
  • Revenue Growth
  • AREC N/A
  • RLMD N/A
  • 52 Week Low
  • AREC $0.41
  • RLMD $0.34
  • 52 Week High
  • AREC $1.78
  • RLMD $7.22
  • Technical
  • Relative Strength Index (RSI)
  • AREC 44.68
  • RLMD 17.00
  • Support Level
  • AREC $0.99
  • RLMD $0.34
  • Resistance Level
  • AREC $1.27
  • RLMD $0.40
  • Average True Range (ATR)
  • AREC 0.08
  • RLMD 0.09
  • MACD
  • AREC -0.03
  • RLMD -0.02
  • Stochastic Oscillator
  • AREC 22.86
  • RLMD 0.72

About AREC American Resources Corporation

American Resources Corp is a next-generation, environmentally, and socially responsible supplier of high-quality raw materials to the new infrastructure market. The firm is focused on the extraction and processing of metallurgical carbon, an essential ingredient used in steelmaking, critical and rare earth minerals for the electrification market, and reprocessed metal to be recycled. The firm has a growing portfolio of operations located in the Central Appalachian basin of eastern Kentucky and southern West Virginia where premium quality metallurgical carbon and rare earth mineral deposits are concentrated. Its business model provides a significant opportunity to scale its portfolio of assets to meet the growing global infrastructure and electrification markets.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: